Role of the accessory gene regulator agr in community-associated methicillin-resistant Staphylococcus aureus pathogenesis

Infect Immun. 2011 May;79(5):1927-35. doi: 10.1128/IAI.00046-11. Epub 2011 Mar 14.

Abstract

The molecular basis underlying the pathogenic success of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is not completely understood, but differential gene expression has been suggested to account at least in part for the high virulence of CA-MRSA strains. Here, we show that the agr gene regulatory system has a crucial role in the development of skin infections in the most prevalent CA-MRSA strain USA300. Importantly, our data indicate that this is due to discrepancies between the agr regulon of CA-MRSA and those of hospital-associated MRSA and laboratory strains. In particular, agr regulation in strain USA300 led to exceptionally strong expression of toxins and exoenzymes, upregulation of fibrinogen-binding proteins, increased capacity to bind fibrinogen, and increased expression of methicillin resistance genes. Our findings demonstrate that agr functionality is critical for CA-MRSA disease and indicate that an adaptation of the agr regulon contributed to the evolution of highly pathogenic CA-MRSA.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Animals
  • Bacterial Proteins / genetics*
  • Community-Acquired Infections / genetics
  • Gene Expression
  • Gene Expression Profiling
  • Gene Expression Regulation, Bacterial / genetics*
  • Methicillin Resistance / genetics
  • Methicillin-Resistant Staphylococcus aureus / genetics*
  • Methicillin-Resistant Staphylococcus aureus / pathogenicity
  • Mice
  • Mice, Nude
  • Oligonucleotide Array Sequence Analysis
  • Regulon / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Staphylococcal Skin Infections / genetics*
  • Staphylococcal Skin Infections / immunology
  • Trans-Activators / genetics*
  • Virulence

Substances

  • Agr protein, Staphylococcus aureus
  • Bacterial Proteins
  • Trans-Activators